Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chuang-Zhou Rao"'
Autor:
Bao Ting Zhu, Qiu-Mei Deng, Hua-Jun Chen, Wen-Zhao Zhong, Wenxian Wang, Jin Kang, Chuang-Zhou Rao, Kai-Cheng Peng, Jin-Ji Yang, Chunwei Xu, Peng Li, Xiang-Peng Chu, Pan Wang, Hua-Fei Chen
Publikováno v:
Genes, Chromosomes and Cancer. 61:177-186
Anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) respond well to ALK tyrosine kinase inhibitors (TKIs), and echinoderm microtubule-associated protein-like 4 (EML4)-ALK-rearranged NSCLC accounts for the majority of those
Autor:
Ke-Lin She, Meiyu Fang, Lei Lei, Jinluan Li, You-cai Zhu, Wu Zhuang, Zongyang Yu, Wen-Bin Gao, Yong Fang, Dong Wang, Xiaohui Chen, Liping Wang, Yinbin Zhang, Wenxian Wang, Yue-Fen Zhou, Zhao-Lei Cui, Liyun Miao, Shi-jie Lan, Chuang-Zhou Rao, Qiming Wang, Yong Song, Hong Wang, Xingxiang Pu, Jian-Hui Huang, Tangfeng Lv, Xin Cai, Chunwei Xu
Publikováno v:
Translational Lung Cancer Research. 9:1853-1861
Background Chemotherapy is the major choice for advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor exon 20 insertion (EGFR ex20ins). The efficacy of pemetrexed-based with other chemotherapy regimens and EGFR ex
Autor:
Chun-Wei, Xu, Wen-Xian, Wang, Dong, Wang, Qi-Ming, Wang, Xing-Xiang, Pu, You-Cai, Zhu, Jian-Hui, Huang, Zong-Yang, Yu, Zhao-Lei, Cui, Xiao-Hui, Chen, Jin-Luan, Li, Yong, Fang, Hong, Wang, Wu, Zhuang, Shi-Jie, Lan, Xin, Cai, Yin-Bin, Zhang, Wen-Bin, Gao, Li-Ping, Wang, Ke-Lin, She, Chuang-Zhou, Rao, Yue-Fen, Zhou, Mei-Yu, Fang, Li-Yun, Miao, Lei, Lei, Tang-Feng, Lv, Yong, Song
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Chemotherapy is the major choice for advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor exon 20 insertion (EGFR ex20ins). The efficacy of pemetrexed-based with other chemotherapy regimens and EGFR e
Autor:
Hongming Pan, D. Zhu, F. Lan, L. Lu, X. Yang, Yong Fang, Chuang-Zhou Rao, Jiawei Shou, W. Hong, Yongyan Wang, Q. Guo, Jun Chen
Publikováno v:
Annals of Oncology. 32:S1021
Autor:
L. Lu, Jiawei Shou, F. Lan, Hongming Pan, Chuang-Zhou Rao, Jun Chen, D. Zhu, X. Yang, Q. Guo, W. Hong, Yong Fang, Yongyan Wang
Publikováno v:
Annals of Oncology. 32:S1021
Autor:
Jiawei Shou, Wei Hong, Yong Fang, Dan Zhu, Jun Chen, Fen Lan, Qunyi Guo, Chuang-Zhou Rao, Hongming Pan, Xinmei Yang, Liqin Lu
Publikováno v:
Journal of Clinical Oncology. 39:e21055-e21055
e21055 Background: Second-line chemotherapy alone, such as docetaxel, is standard of care for patients (pts) with advanced NSCLC, but the efficacy is poor. Anti-angiogenic drugs plus chemotherapy had shown to significantly prolong progression-free su
Autor:
Hongming Pan, Chuang-Zhou Rao, F. Lan, Jiawei Shou, D. Zhu, X. Yang, Yong Fang, W. Hong, Jun Chen, Y. Zhou
Publikováno v:
Journal of Thoracic Oncology. 16:S682